Skip to main content
Fig. 3 | Clinical Epigenetics

Fig. 3

From: Dysregulation and prognostic potential of 5-methylcytosine (5mC), 5-hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC), and 5-carboxylcytosine (5caC) levels in prostate cancer

Fig. 3

Representative images of 5fC immunoreactivity in malignant and non-malignant prostate tissue samples. a TMA core containing both malignant (IHC score = 0, arrowheads), and NM (IHC score = 0, arrows) glands. b Strong 5fC staining in a malignant core (IHC score = 2). c Moderate 5fC staining in a malignant core (IHC score = 1). d Weak 5fC staining in a malignant core (IHC score = 0)

Back to article page